Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

(Human Secretin for Injection)
   >> Indications
   >> Dosing

click here for more details...
Clinical Research

Basic Pancreas

Pancreas Function

Pancreas Diseases


  >>Acute Pancreatitis

  >>Chronic Pancreatitis

  >>Pancreatic Cancer

Endoscopic Procedures




  >>Combine EUS-ePFT

Dynamic Imaging Modalities




click here for more details...
Welcome to ChiRhoClin, Inc.


ChiRhoClin, Inc., a Maryland based family run corporation founded in 1991 by Dr. Edward D. Purich, is a research and development oriented pharmaceutical company focused on developing orphan drug products for the gastrointestinal and radiological community.  Our emphasis is to develop orphan drug products that will diagnose and treat pancreatic gastrointestinal diseases and encourage research in the pancreatic area through our small pancreatic grant program. 


ChiRhoClin's product is ChiRhoStim® (Human Secretin for Injection) an orphan drug that aids in the diagnoses of pancreatic cancer and pancreatic exocrine dysfunction.

ChiRhoStim® (Human Secretin for Injection) is approved for Pancreatic Function Testing, facilitating cannulation during ERCP, and Gastrinoma Testing.  In addition, secretions of the pancreatic fluid after secretin stimulation can be used in situ for imaging modalities such as MRCP, CT, and EUS.

click here for more details...
 For additional information, please visit these websites on Human Secretin.
(Human Secretin for Injection)
Now commercially available
Call 1-877-CRC-4888 or
Secretin-Enhanced MRCP
For information, pictures, and
journal articles,
Please visit
Zollinger Ellison Syndrome (Gastrinoma)
For testing protocols, CPT coding, and ordering info, 
ChiRhoClin, Inc. is exhibiting at ACG 2018 Booth ...
[Oct 02, 2018]
ChiRhoStim® (Human Secretin for Injection) FDA app...
[Jul 25, 2017]
View all news...

July 2017  Trout AT, et al.  Secret...

click here for more details...